Regulation of E-cadherin gene expression during tumor progression: The role of a new Ets-binding site and the E-pal element

Experimental Cell Research

Volumn 248, Issue 2, 1999, Pages 358-371

  Rodrigo, Isabel ^a   Cato, Andrew C B ^b   Cano, Amparo ^a  

^a CSIC   (Spain)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

E cadherin promoter; Ets factors; In vivo footprinting; Keratinocytes; Methylation

Indexed keywords

CIS ACTING ELEMENT; TRANS ACTING FACTOR; UVOMORULIN;

ANIMAL CELL; ARTICLE; DNA FOOTPRINTING; DNA METHYLATION; GENE EXPRESSION; GENE SILENCING; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GROWTH;

ANIMALIA; MURINAE;

EID: 0033134125     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4438     Document Type: Article

References (53)

1. Takeichi M. Cadherin cell adhesion receptors as morphogenetic regulators. Science. 251:1991;1451-1455.
2. Huber O., Bierkamp C., Kemler R. Cadherins and catenins in development. Curr. Opin. Cell Biol. 8:1996;685-691.
3. Larue L., Antos C., Butz S., Huber O., Delmas V., Dominis M., Kemler R. A role for cadherins in tissue formation. Development. 122:1996;3185-3194.
4. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5:1993;806-811.
5. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1198:1994;11-26.
6. Umbas R., Schalken J. A., Aalders T. W., Carter B. S., Karthaus H. F., Schaafsma H. E., Debruyne F. M. J., Isaacs W. B. Expression of the cell adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 52:1992;5104-5109.
7. Gamallo C., Palacios J., Suárez A., Pizarro A., Navarro P., Quintanilla M., Cano A. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinomas. Am. J. Pathol. 142:1993;987-993.
8. Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasivenesss of human carcinoma cells. J. Cell Biol. 113:1991;173-185.
9. Vleminckx K., Vakaet L. J., Mareel M., Fiers W., Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 66:1991;107-119.
10. Navarro P., Gómez M., Pizarro A., Gamallo C., Quintanilla M., Cano A. A role for the cell-cell adhesion molecule E-cadherin during tumor progression in mouse skin carcinogenesis. J. Cell Biol. 115:1991;517-533.
11. Becker K. F., Atkinson M. J., Reich U., Becker I., Nekarda H., Siewert J. R., Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54:1994;3845-3852.
12. Berx G., Cleton-Jansen A. M., Nollet F., de Leeuw W. J., van deVijver M, Cornelisse C., Van Roy F. E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J. 14:1995;6107-6115.
13. Risinger J. I., Berchuck A., Kohler M. F., Boyd J. Mutations of the E-cadherin gene in human gynecological cancers. Nature Genet. 7:1994;98-102.
14. Behrens J., Löwrick O., Klein H. L., Birchmeier W. The E-cadherin promoter: functional analysis of a GC-rich region and an epithelial cell-specific palindromic regulatory element. Proc. Natl. Acad. Sci. USA. 88:1991;11495-11499.
15. Ringwald M., Baribault H., Schmidt C., Kemler R. The structure of the gene coding for the mouse cell adhesion molecule uvomorulin. Nucleic Acids Res. 19:1991;6533-6539.
16. Bussemakers M. J., Giroldi L. A., van Bokhoven A., Schalken J. A. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterization of the human E-cadherin gene promoter. Biochem. Biophys. Res. Commun. 203:1994;1284-1290.
17. Hennig G., Löwrick O., Birchmeier W., Behrens J. Mechanisms identified in the transcriptional control of epithelial gene expression. J. Biol. Chem. 271:1996;595-602.
18. Giroldi L. A., Bringuier P-P., de Weijert M., Jansen C., van Bokhoven A., Schalken J. A. Role of E-boxes in the repression of E-cadherin expression. Biochem. Biophys. Res. Commun. 241:1997;453-458.
19. Faraldo M. L., Rodrigo I., Behrens J., Birchmeier W., Cano A. Analysis of the E-cadherin and P-cadherin promoters in murine keratinocyte cell lines from different stages of mouse skin carcinogenesis. Mol. Carcinog. 20:1997;33-47.
20. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA. 92:1995;7416-7419.
21. Graff J. R., Herman J. G., Lapidus R. G., Chopra H., Xu R., Jarrard D. F., Isaacs W. B., Pitha P. M., Davidson N. E., Baylin S. B. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55:1995;5195-5199.
22. Hennig G., Behrens J., Truss M., Frisch S., Reichmann E., Birchmeier W. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoterin vivo. Oncogene. 11:1995;475-484.
23. Ji X., Woodard A. S., Rimm D. L., Fearon E. R. Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ. 8:1997;773-778.
24. Burns P. A., Kemp C. J., Gannon J. V., Lane D. P., Bremner R., Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene. 6:1991;2363-2369.
25. Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. PCR Protocols: A Guide to Methods and Applications. 1990;Academic Press, San Diego.
26. Monté D., Baert J. L., Defossez P. A., de Launoit Y., Stéhelin D. Molecular cloning and characterization of human ERM, a new member of the Ets family closely related to mouse PEA3 and ER81 transcription factors. Oncogene. 9:1994;1397-1406.
27. Schneikert J., Lutz Y., Wasylyk B. Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family. Oncogene. 7:1992;249-256.
28. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
29. Mueller P. R., Wold B. In vivo. Science. 246:1989;780-786.
30. Münsterberg A. E., Kitajewski J., Bumcrot D. A., Mahon A. P., Lassar A. B. Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev. 9:1995;2911-2922.
31. Gunther C. V., Nye J. A., Bryner R. S., Graves B. J. Sequence-specific DNA binding of the proto-oncoproteinets-1. Genes Dev. 4:1990;667-679.
32. Xin J., Cowie A., Lachance P., Hassell J. A. Molecular cloning and characterization of PEA3, a new member of theEts. Genes Dev. 6:1992;481-496.
33. Tymms M. J., Ng A. Y., Thomas R. S., Scutte B. C., Zhou J., Eyre H. J., Sutherland G. R., Seth A., Rosenberg M., Papas T., Debouck C., Kola I. A novel epithelial-expressed ETS gene, ELF3: Human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene. 15:1997;2449-2462.
34. Brown T. A., McKnight S. L. Specificities of protein-protein and protein-DNA interaction of GABPα and two newly definedets. Genes Dev. 6:1992;2502-2512.
35. Wu H. W., Moulton K., Horvai A., Parik S., Glass C. K. Combinatorial interactions between AP-1 and ets domain proteins contribute to the developmental regulation of the macrophage scavenger receptor gene. Mol. Cell. Biol. 14:1994;2129-2139.
36. Lee J. H., Jang S. I., Yang J. M., Markova N. G., Steinert P. M. The proximal promoter of the human transglutaminase 3 gene: Stratified squamous epithelial-specific expression in cultured cells is mediated by binding of Sp1 andets. J. Biol. Chem. 271:1996;4561-4568.
37. Nakae K., Nakajima K., Inazawa J., Kitaoka T., Hirano T. ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun. J. Biol. Chem. 270:1995;23795-23800.
38. Gory S., Dalmon J., Prandini M. H., Kortulewski T., de Launoit Y., Huber P. Requirement of a GT box (Sp1 site) and two Ets binding sites for vascular endothelial cadherin gene transcription. J. Biol. Chem. 273:1998;6750-6755.
39. Wasylyk B., Wasylyk C., Flores P., Begue A., Leprince D., Stehelin D. The c-ets. Nature. 346:1990;191-193.
40. Pankov R., Neznanov N., Umezawa A., Oshima R. G. AP-1, ETS, and transcriptional silencers regulate retinoic acid-dependent induction of keratin 18 in embryonic cells. Mol. Cell. Biol. 14:1994;7744-7757.
41. Gum R., Lengyels E., Juarez J., Chen J. H., Sato H., Seiki M., Boyd D. Stimulation of 92-kDa gelatinase B promoter activity byrasets. J. Biol. Chem. 271:1996;10672-10680.
42. Gégonne A., Bosselut R., Bailly R. A., Ghysdael J. Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1. EMBO J. 12:1993;1169-1178.
43. Dittmer J., Gégonne A., Gitlin S. D., Ghysdael J., Brady J. N. Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through and inverted CACCC motif and regulates promoter activity in cooperation with Ets1. J. Biol. Chem. 269:1994;21428-21434.
44. Dang W., Sun X-H., Sen R. ETS-mediated cooperation between basic helix-loop-helix motifs of the immunoglobulin μ heavy-chain gene enhancer. Mol. Cell. Biol. 18:1998;1477-1488.
45. Andreoli J. M., Jang S. I., Chung E., Coticchia C. M., Steinert P. M., Markova N. G. The expression of a novel, epithelium-specific ets transcription factor is restricted to the most differentiated layers in the epidermis. Nucleic Acids Res. 25:1997;4287-4295.
46. Oettgen P., Alani R. M., Barcinski M. A., Brown L., Akbarali Y., Boltax J., Kunsch C., Munger K., Libermann T. A. Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of theets. Mol. Cell. Biol. 17:1997;4419-4433.
47. Trimble M. S., Xin J-H., Guy C. T., Muller W. J., Hasell J. A. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene. 8:1993;3037-3042.
48. Baert J. L., Monté D., Musgrove E. A., Albagli O., Sutherland R. L., de Launoit Y. Expression of the PEA3 group of ETS-related transcription factors in human breast cancer cells. Int. J. Cancer. 70:1997;590-597.
49. Kola I., Brookes S., Green A. R., Garber R., Tymms M., Papas T. S., Seth A. TheEts1. Proc. Natl. Acad. Sci. USA. 90:1993;7588-7592.
50. Wernert N., Gilles F., Fafeur V., Bouali F., Raes M-B., Pyke C., Dupressoir T., Seitz G., Vandenbunder B., Stehelin D. Stromal expression of c-ets1. Cancer Res. 54:1994;5683-5688.
51. Kaya M., Yoshida K., Higashino F., Mitaka T., Ishii S., Fujinaga K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene. 12:1996;221-227.
52. Fafeur V., Tulasne D., Quéva C., Vercamer C., Dimster V., Mattot V., Stehelin D., Desbiens X., Vandenbunder B. The ETS1 transcription factor is expressed during epithelial-mesenchymal transitions in the chick embryo and is activated in scatter factor-stimulated MDCK epithelial cells. Cell Growth Differ. 8:1997;655-665.
53. Frisch S. M. The epithelial cell default-phenotype hypothesis and its implications for cancer. BioEssays. 19:1997;705-709.